PCOS Has Been Renamed PMOS: Why The New Name Matters For Your Health

If you are one of the millions of women diagnosed with PCOS and have felt like your diagnosis did not quite capture everything you were experiencing, the change to PMOS could be the beginning of finally getting the full picture — and care — you deserve.

According to the World Health Organization (WHO), PCOS affects 10-13% of reproductive-aged women. If you are one of them, I have some important news for you. As of May 12, 2026, the condition has an official new name: polyendocrine metabolic ovarian syndrome (PMOS).

This might sound like a technicality, but I promise you it is so much more than that. The old name, PCOS, has left a lot of women feeling dismissed, confused, and without the full picture of what is happening inside their bodies. In this article, you'll learn why the name changed, what it means, and how it could change the care you receive going forward.

What Is PMOS (Previously Known as PCOS)?

PMOS is one of the most common hormonal conditions in women of reproductive age. It affects 10-13% of women of reproductive age worldwide - that is more than 170 million people. Despite being this common, the WHO estimates that up to 70% of women with the condition are never diagnosed (1).

PMOS affects multiple body systems at once. Symptoms vary widely from woman to woman, but can include:

Irregular or missing periods
Excess hair growth on the face or body
Hair thinning or loss on the scalp
Acne, sometimes particularly along the jawline and chin
Difficulty managing weight
Mood changes, anxiety, or depression
Fertility challenges
Increased risk of insulin resistance, type 2 diabetes, and cardiovascular concerns

If that list feels surprisingly wide-ranging for a condition named after ovaries, that is exactly the problem the new name was designed to fix.

Why Did the Name Change? The Problem With "Polycystic Ovary Syndrome"

The old name had two issues:

The "cysts" problem. The name polycystic ovary syndrome implies that ovarian cysts are the defining feature of the condition. They are not. Many women with the condition have never had cysts on their ovaries at all. The "polycystic" appearance on ultrasound actually refers to multiple small follicles (not true cysts) and is not required for a diagnosis. This led to a painful and frustrating pattern: women without visible cysts were told they did not have PCOS, even when they had many other features.

The "ovarian" problem. Naming the condition after the ovaries framed it as primarily a reproductive or gynecological issue. That led doctors to focus on fertility and periods while the metabolic and endocrine dimensions of the condition were under-addressed or ignored entirely.

The Lancet paper announcing the new name put it plainly: the term PCOS is "inaccurate, implying pathological ovarian cysts, obscuring diverse endocrine and metabolic features, and contributing to delayed diagnosis, fragmented care, and stigma, while curtailing research and policy framing" (2).

What Does “Polyendocrine Metabolic Ovarian Syndrome” Mean?

The new name, polyendocrine metabolic ovarian syndrome, does a better job naming what this condition is.

Poly-endocrine = multiple hormone systems are involved, not just reproductive hormones
Metabolic = insulin resistance, blood sugar regulation, and cardiovascular risk are core features
Ovarian = ovulatory dysfunction does remain a key part of the condition

The ovaries are still in the name, because ovarian function matters... But now, so does everything else.

To learn more about hormonal balance and how it affects the whole body, read this article: Supporting Hormone Balance Naturally With Seed Cycling

How Long Did This Take, and Who Was Involved?

This name change was the result of more than a decade of work involving over 22,000 patients and healthcare professionals from around the world (2).

The process was led by Professor Helena Teede at Monash University in Australia and was formally published in The Lancet on May 12, 2026. It involved 56 leading academic, clinical, and patient organizations, including the Endocrine Society, as well as many surveys, workshops, and rigorous consensus processes across multiple continents (2). More than 86% of patients and 70% of healthcare professionals surveyed supported the name change (2). The winning name, PMOS, was chosen because it prioritized scientific accuracy, reduced stigma, and could translate clearly across different cultures and languages (2).

The announcement also included a commitment to update clinical guidelines, medical education curricula, and international disease classification systems over the next three years, so the change is not just symbolic. It will reshape how this condition is taught, researched, and treated (2).

Why the Delay in PCOS Diagnosis Has Always Been a Real Problem

Research has long confirmed what many women with PCOS already knew from personal experience: getting diagnosed takes far too long, and it should not.

A study found that one-third of women with PCOS reported waiting more than two years before receiving a diagnosis, and nearly half consulted three or more healthcare professionals before finally getting answers. Only 35% of women said they were satisfied with their diagnosis experience (3).

That delay means years without the right support for metabolic health, mental health (4), skin concerns, and long-term cardiovascular wellness (and a lot of frustration). The renaming of the condition is a meaningful step toward changing that - because when the name accurately reflects what PMOS is, doctors are better equipped to recognize it, and women are better equipped to advocate for themselves.

To learn more about how hormones affect mood and mental health, read this article: PMS: What It Is, Why It Happens, & How To Feel Better During Your Luteal Phase

What The Name Change Means For Women with PCOS

If you have a PCOS diagnosis, your condition has not changed. Your biology is the same. But the renaming is a reminder to take stock of whether your care reflects the full scope of what PMOS is.

A few questions worth asking your healthcare provider:

Has my metabolic health been evaluated, including fasting insulin, blood sugar, and cholesterol?
Has my mental health been addressed as part of my overall care plan?
Am I being monitored for long-term concerns associated with PMOS beyond my periods or fertility?
Is my care team treating this as a whole-body hormonal condition?

Summary

PCOS has been officially renamed PMOS - polyendocrine metabolic ovarian syndrome. If you are one of the millions of women with this diagnosis, and you have ever felt like your diagnosis did not quite capture everything you were experiencing, you’re not alone and this change could be the beginning of finally getting the full picture (and care) you deserve.

The old name framed the condition as primarily a reproductive issue, which led to years of missed diagnoses, fragmented care, and women being dismissed by providers who were looking at only part of the picture. The new name reflects what researchers have known for a long time: this is a whole-body hormonal condition involving the endocrine system, metabolism, mental health, skin, and more.

Nothing about your biology has changed, but the language around it finally has - and that matters for how this condition is diagnosed, researched, and treated going forward. If you have a PCOS diagnosis, now is a great time to revisit your care and make sure it reflects the full scope of who you are and what your body needs.